Please select a day by clicking on one of the links below.
-
Thursday 9th October 2014
To download the final programme, please click on the icon on the right hand side.
Welcome Address by the Chair of the British HIV Association
Dr David Asboe, Chelsea and Westminster Hospital, London
BHIVA Invited Lecture
Hepatitis C treatment: from bench to bedside
Dr Janice Main, Imperial College Healthcare NHS Trust, London
BHIVA is grateful that this session has been supported by sponsorship provided by Janssen.
BHIVA Foundation Lecture
CCR5 knock-out gene therapy trials
Dr Geoffrey Nichol, Sangamo BioSciences, USA
BHIVA Audit Session
Management of pregnancy in HIV: survey results
Dr Yvonne Gilleece, Royal Sussex County Hospital, Brighton
BHIVA Guidelines Session
Immunisation of HIV-infected adults
Professor Anna Maria Geretti, University of Liverpool
Treatment of HIV-1-positive adults with antiretroviral therapy
Dr Duncan Churchill, Royal Sussex County Hospital, Brighton
Management of hepatitis viruses in adults infected with HIV
Dr Ed Wilkins, North Manchester General Hospital
BHIVA Lunchtime Workshop 1 - Difficult antiretroviral (ARV) decisions: case presentations
Managing a challenging resistance pattern in pregnancy
Dr Gareth Hughes, Sheffield Teaching Hospitals NHS Foundation Trust
Unmasking resistance through cardiovascular risk
Dr Naomi Sutton, Royal Hallamshire Hospital, Sheffield
A well-informed gamble?
Dr Meghan Perry, Western General Hospital, Edinburgh
BHIVA Plenary Session 1 - Primary infection: to treat or not to treat?
The patient perspective
Mr Simon Collins, HIV i-Base
The clinician perspective
Dr Sarah Fidler, Imperial College London
The public health perspective
Dr Valerie Delpech, Public Health England
BHIVA Plenary Session 2
First-line highly active antiretroviral therapy (HAART): where now?
Dr Chloe Orkin, Barts Health NHS Trust, London
New drugs, new rules: balancing the books
Dr Nicola Mackie, Imperial College Healthcare NHS Trust, London
BHIVA Community Symposium - More than pills: what do people with HIV need to live a long and healthy life?
Life expectancy
Dr Paddy Mallon, Mater Misericordiae University Hospital, Dublin, Ireland
Quality of life
Dr Richard Harding, King’s College Hospital, London
The patient perspective
Miss Maureen Kiwanuka, Positively UK
Mr David Randolph, Patient representative
BHIVA Plenary Session 3
The AIDS Clinical Trials Group (ACTG) and the impact on the treatment of HIV: past, present and for the future
Professor Jeffery Lennox, Emory University School of Medicine, Atlanta, Georgia, USA
A new collaboration in blood-borne and sexually transmitted infections research
Professor Caroline Sabin, University College London
BHIVA is grateful that this session has been supported by sponsorship provided by MSD Ltd.